Upstream Bio Inc: Piper Sandler cuts target price to $40 from $75
UPB•Piper Sandler cut its target price for Upstream Bio Inc to $40 from $75.
Related News
ALPS Group meets Malaysian Consulate in New York to discuss US engagement
ALPS•
Prime Medicine announces pricing of public offering of common stock
PRME•
India holds Pernod, Diageo Scotch shipments as investigators seek higher tariff
DEO•
Europe Capital Partners sees US interest rates staying higher for longer
TLT•
Stocks rally as CoreWeave soothes, bonds reel on rate hike fears
SPY•